AeroLeads people directory · profile
Philippe Wiesel Email & Phone Number
Chief Medical Officer
at
AgomAb Therapeutics
1 work email found
@genkyotex.com
LinkedIn matched
✓ Verified Jul 2026
4 data sources
Profile completeness 100%
Current company
Role
Chief Medical Officer
Location
Arlington, Massachusetts, United States
Who is Philippe Wiesel? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Philippe Wiesel is listed as Chief Medical Officer at AgomAb Therapeutics, based in Arlington, Massachusetts, United States. AeroLeads shows a work email signal at genkyotex.com and a matched LinkedIn profile for Philippe Wiesel.
Philippe Wiesel previously worked as Chief Medical Officer at Genkyotex S.A and Partner at Philippe Wiesel Biopharmaceutical Consulting. Philippe Wiesel holds Md, Medicine from Lausanne University Medical School.
Company email context
Email format at AgomAb Therapeutics
This section adds company-level context without repeating Philippe Wiesel's masked contact details.
{first}.{last}@genkyotex.com
86% confidence
AeroLeads found 1 current-domain work email signal for Philippe Wiesel. Compare company email patterns before reaching out.
Profile bio
About Philippe Wiesel
Philippe joined AgomAb as CMO in 2021. He was previously the CMO at Genkyotex where he led the company’s clinical development activities for the treatment of several fibrotic disorders in the liver, lung, and kidney. Prior to this role, Philippe co-founded Genexion, which was focused on developing early-stage clinical assets in partnership with emerging biotech companies. Before this, Philippe was Medical Director at EMD Serono’s Swiss and US offices, where he was involved with the global development of several biologics. In particular, he led the late-stage clinical development of Raptiva, achieving the first marketing authorization in Europe for a biological therapy targeting psoriasis. Philippe received an MD in Medicine from Lausanne University Medical School and was a postdoctoral researcher at Harvard University Medical School and the Division of Hypertension at Lausanne University.
Listed skills include Drug Development, Clinical Development, Biotechnology, Translational Research, and 13 others.
Current workplace
Philippe Wiesel's current company
Company context helps verify the profile and gives searchers a useful next step.
8 roles
Philippe Wiesel work experience
A career timeline built from the work history available for this profile.
Chief Medical Officer
Current
Jan 2021 - Present
Chief Medical Officer
Genkyotex is developing first-in-class, small molecule therapeutics that selectively inhibit the NOX family of enzymes. In humans, these enzymes play an important role in maintaining normal function, but under various conditions they become overactive and lead to disease. Targeting NOX enzymes may lead to more effective medical treatments as they address the source of the disease. By targeting the various forms of the NOX enzyme, Genkyotex is able to develop specific drugs against various diseases.Using a unique proprietary screening platform, Genkyotex has identified novel NOX inhibitors with the potential to treat disease areas with a high clinical need and large market potential. The company’s lead product is GKT137831, a dual inhibitor of NOX4 and NOX1, which is in clinical development for the treatment of diabetic nephropathy.Genkyotex is headquartered in Plan-Les-Ouates near Geneva, Switzerland, with a subsidiary Genkyotex Innovation SAS based in Archamps, France. The Company was founded in 2006 by an international group of scientific experts in the field of free radical generating enzymes with backing from Geneva incubator Eclosion, FAE and Sefti. Subsequently further investment has been provided by Edmond de Rothschild Investment Partners , Vesalius BioCapital, MP Healthcare Venture Management.
Aug 2010 - Dec 2020
Partner
Philippe Wiesel Biopharmaceutical Consulting
Jan 2008 - Jan 2011
Co-Founder, Head Business Development & Consulting
Genexion Sa
Mar 2004 - Dec 2007
Medical Director New Therapies
Jan 2000 - Feb 2004
Post Doctoral Research Fellow
Jun 1997 - Dec 1999
Post Doctoral Research Fellow
Division Of Hypertension Lausanne University
Jan 1994 - May 1997
1 education record
Philippe Wiesel education
-
Lausanne University Medical School
FAQ
Frequently asked questions about Philippe Wiesel
Quick answers generated from the profile data available on this page.
What company does Philippe Wiesel work for?
Philippe Wiesel works for AgomAb Therapeutics.
What is Philippe Wiesel's role at AgomAb Therapeutics?
Philippe Wiesel is listed as Chief Medical Officer at AgomAb Therapeutics.
What is Philippe Wiesel's email address?
AeroLeads has found 1 work email signal at @genkyotex.com for Philippe Wiesel at AgomAb Therapeutics.
Where is Philippe Wiesel based?
Philippe Wiesel is based in Arlington, Massachusetts, United States while working with AgomAb Therapeutics.
What companies has Philippe Wiesel worked for?
Philippe Wiesel has worked for Agomab Therapeutics, Genkyotex S.A, Philippe Wiesel Biopharmaceutical Consulting, Genexion Sa, and Serono International Sa.
How can I contact Philippe Wiesel?
You can use AeroLeads to view verified contact signals for Philippe Wiesel at AgomAb Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Philippe Wiesel attend?
Philippe Wiesel holds Md, Medicine from Lausanne University Medical School.
What skills is Philippe Wiesel known for?
Philippe Wiesel is listed with skills including Drug Development, Clinical Development, Biotechnology, Translational Research, Clinical Trials, Clinical Research, Pharmaceutical Industry, and Oncology.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial